Skip to main navigation Skip to search Skip to main content

A Phase 3 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Once-Daily Oral Doses of 75mg Azimilide Dihydrochloride on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits....

Project: Research

Project Details

StatusFinished
Effective start/end date06/18/1204/21/14

Funding

  • Forest Research Institute: $5,500.00